Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 330 articles:
HTML format



Single Articles


    May 2022
  1. WILLEKENS R, Puig-Asensio M, Suanzes P, Fernandez-Hidalgo N, et al
    Empirical use of beta-lactam/beta-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-weighted cohort study.
    J Antimicrob Chemother. 2022 May 12. pii: 6584695. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  2. FLATEAU C, Riazi A, Cassard B, Camus M, et al
    Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?-authors' response.
    J Antimicrob Chemother. 2022 Apr 27. pii: 6574660. doi: 10.1093.
    PubMed    


  3. GARCIA-FIERRO R, Drapeau A, Dazas M, Saras E, et al
    Comparative phylogenomics of ESBL-, AmpC- and carbapenemase-producing Klebsiella pneumoniae originating from companion animals and humans.
    J Antimicrob Chemother. 2022;77:1263-1271.
    PubMed     Abstract available


  4. ABBOTT IJ, van Gorp E, Wyres KL, Wallis SC, et al
    Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model.
    J Antimicrob Chemother. 2022;77:1324-1333.
    PubMed     Abstract available


  5. MILTGEN G, Martak D, Valot B, Kamus L, et al
    One Health compartmental analysis of ESBL-producing Escherichia coli on Reunion Island reveals partitioning between humans and livestock.
    J Antimicrob Chemother. 2022;77:1254-1262.
    PubMed     Abstract available


  6. BASTIDA C, Hernandez-Tejero M, Cariqueo M, Aziz F, et al
    Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections.
    J Antimicrob Chemother. 2022;77:1365-1371.
    PubMed     Abstract available


  7. MEI CY, Jiao X, Wu H, Wang ZY, et al
    Detection of cfr in Leclercia adecarboxylata from pig feed, China.
    J Antimicrob Chemother. 2022;77:1500-1502.
    PubMed    


  8. TAIT JR, Barnett TC, Rogers KE, Lee WL, et al
    Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.
    J Antimicrob Chemother. 2022 Apr 26. pii: 6573986. doi: 10.1093.
    PubMed     Abstract available


  9. LOPEZ-VARELA E, Abulfathi AA, Strydom N, Goussard P, et al
    Drug concentration at the site of disease in children with pulmonary tuberculosis.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573919. doi: 10.1093.
    PubMed     Abstract available


  10. CHAGNEAU CV, Alcouffe O, Grare M, Oswald E, et al
    Screening for beta-lactam resistance by penicillin G in the Streptococcus anginosus group challenged by rare strains with altered PBPs.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573466. doi: 10.1093.
    PubMed     Abstract available


  11. ENER B, Ergin C, Gulmez D, Agca H, et al
    Frequency of azole resistance in clinical and environmental strains of Aspergillus fumigatus in Turkey: a multicentre study.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571734. doi: 10.1093.
    PubMed     Abstract available


  12. SCHWENDENER S, Perreten V
    The bla and mec families of beta-lactam resistance genes in the genera Macrococcus, Mammaliicoccus and Staphylococcus: an in-depth analysis with emphasis on Macrococcus.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571732. doi: 10.1093.
    PubMed     Abstract available


  13. SIMOS PA, Holland DJ, Stewart A, Isler B, et al
    Clinical prediction scores and the utility of time to blood culture positivity in stratifying the risk of infective endocarditis in Staphylococcus aureus bacteraemia.
    J Antimicrob Chemother. 2022 Apr 15. pii: 6568605. doi: 10.1093.
    PubMed     Abstract available


  14. CORTES MF, Andre C, Martins Simoes P, Corvec S, et al
    Persistence of a multidrug-resistant worldwide-disseminated methicillin-resistant Staphylococcus epidermidis clone harbouring the cfr linezolid resistance gene in a French hospital with evidence of interspecies transfer to several Staphylococcus aureu
    J Antimicrob Chemother. 2022 Apr 15. pii: 6568602. doi: 10.1093.
    PubMed     Abstract available


  15. GIULIANO S, Angelini J, Flammini S, Tascini C, et al
    Comment on: Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?
    J Antimicrob Chemother. 2022 Apr 4. pii: 6562960. doi: 10.1093.
    PubMed    


    March 2022
  16. BIEZ L, Bonnin RA, Naas T, Dortet L, et al
    Characterization of VIM-1-, NDM-1- and OXA-48-producing Citrobacter freundii in France.
    J Antimicrob Chemother. 2022;77:1200-1202.
    PubMed    


  17. MUDDE SE, Upton AM, Lenaerts A, Bax HI, et al
    Delamanid or pretomanid? A Solomonic judgement!
    J Antimicrob Chemother. 2022;77:880-902.
    PubMed     Abstract available


  18. GOMIS-FONT MA, Cabot G, Lopez-Arguello S, Zamorano L, et al
    Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones.
    J Antimicrob Chemother. 2022;77:957-968.
    PubMed     Abstract available


  19. PANT N, Wallis SC, Roberts JA, Eisen DP, et al
    In vitro effect of synovial fluid from patients undergoing arthroplasty surgery on MRSA biofilm formation.
    J Antimicrob Chemother. 2022;77:1041-1044.
    PubMed     Abstract available


  20. EMERAUD C, Petit C, Gauthier L, Bonnin RA, et al
    Emergence of VIM-producing Enterobacter cloacae complex in France between 2015 and 2018.
    J Antimicrob Chemother. 2022;77:944-951.
    PubMed     Abstract available


  21. REYNOLDS R, Mushtaq S, Allen MK, Horner C, et al
    Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance.
    J Antimicrob Chemother. 2022;77:1206-1208.
    PubMed    


  22. FALCONE M, Tiseo G, Arcari G, Leonildi A, et al
    Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020-21.
    J Antimicrob Chemother. 2022;77:1140-1145.
    PubMed     Abstract available


  23. WANG W, Hu Y, Baker M, Dottorini T, et al
    Novel SCCmec type XV (7A) and two pseudo-SCCmec variants in foodborne MRSA in China.
    J Antimicrob Chemother. 2022;77:903-909.
    PubMed     Abstract available


  24. LI D, Li P, Peng M, Zhao X, et al
    Transmission barrier of the blaKPC plasmid mediated by type I restriction-modification systems in Escherichia coli.
    J Antimicrob Chemother. 2022;77:952-956.
    PubMed     Abstract available


  25. MAGALLON A, Amoureux L, Garrigos T, Sonois M, et al
    Role of AxyABM overexpression in acquired resistance in Achromobacter xylosoxidans.
    J Antimicrob Chemother. 2022;77:926-929.
    PubMed     Abstract available


  26. MARTIN-LOECHES I, Timsit JF, Kollef MH, Wunderink RG, et al
    Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
    J Antimicrob Chemother. 2022;77:1166-1177.
    PubMed     Abstract available


  27. VEHRESCHILD MJGT, Ducher A, Louie T, Cornely OA, et al
    An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones.
    J Antimicrob Chemother. 2022;77:1155-1165.
    PubMed     Abstract available


  28. LIANG J, Macesic N, Blakeway L
    Comment on: Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2022 Mar 24. pii: 6553323. doi: 10.1093.
    PubMed    


  29. GEORGIOU PC, Arendrup MC, Meletiadis J
    Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates.
    J Antimicrob Chemother. 2022 Mar 22. pii: 6551886. doi: 10.1093.
    PubMed     Abstract available


  30. KIRCHHOFF L, Dittmer S, Furnica DT, Buer J, et al
    Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
    J Antimicrob Chemother. 2022 Mar 15. pii: 6548677. doi: 10.1093.
    PubMed     Abstract available


  31. BATESON A, Ortiz Canseco J, McHugh TD, Witney AA, et al
    Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid.
    J Antimicrob Chemother. 2022 Mar 9. pii: 6544883. doi: 10.1093.
    PubMed     Abstract available


  32. UPTON CM, Steele CI, Maartens G, Diacon AH, et al
    Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB).
    J Antimicrob Chemother. 2022 Mar 8. pii: 6543975. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  33. MELETIADIS J, Efstathiou I, van der Lee HAL, Astvad KMT, et al
    Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?
    J Antimicrob Chemother. 2022 Feb 23. pii: 6534628. doi: 10.1093.
    PubMed     Abstract available


  34. BAE M, Jung J
    Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study-authors' response.
    J Antimicrob Chemother. 2022;77:859-860.
    PubMed    


  35. BURY D, Wolfs TFW, Ter Heine R, Muilwijk EW, et al
    Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort study.
    J Antimicrob Chemother. 2022;77:699-703.
    PubMed     Abstract available


  36. FOSTERVOLD A, Hetland MAK, Bakksjo R, Bernhoff E, et al
    A nationwide genomic study of clinical Klebsiella pneumoniae in Norway 2001-15: introduction and spread of ESBLs facilitated by clonal groups CG15 and CG307.
    J Antimicrob Chemother. 2022;77:665-674.
    PubMed     Abstract available


  37. ALIABADI S, Jauneikaite E, Muller-Pebody B, Hope R, et al
    Exploring temporal trends and risk factors for resistance in Escherichia coli-causing bacteraemia in England between 2013 and 2018: an ecological study.
    J Antimicrob Chemother. 2022;77:782-792.
    PubMed     Abstract available


  38. HAGIYA H, Otsuka F
    Comment on: Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study.
    J Antimicrob Chemother. 2022;77:857-858.
    PubMed    


  39. MARTELLI F, AbuOun M, Cawthraw S, Storey N, et al
    Detection of the transferable tigecycline resistance gene tet(X4) in Escherichia coli from pigs in the United Kingdom.
    J Antimicrob Chemother. 2022;77:846-848.
    PubMed    


  40. LUO H, Chen W, Mai Z, Yang J, et al
    Development and application of Cas13a-based diagnostic assay for Neisseria gonorrhoeae detection and azithromycin resistance identification.
    J Antimicrob Chemother. 2022;77:656-664.
    PubMed     Abstract available


  41. FIFER H, Schaefer U, Pitt R, Allen H, et al
    Use of genomics to investigate Neisseria gonorrhoeae antimicrobial susceptibility testing discrepancies.
    J Antimicrob Chemother. 2022;77:849-850.
    PubMed    


  42. KELLY J, Tysall L, Dewar S
    Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
    J Antimicrob Chemother. 2022 Feb 15. pii: 6528651. doi: 10.1093.
    PubMed     Abstract available


  43. CHUANG YC, Tseng TC, Wang JT, Lin CY, et al
    Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
    J Antimicrob Chemother. 2022 Feb 10. pii: 6525717. doi: 10.1093.
    PubMed     Abstract available


  44. GOLDEN AR, Baxter M, Adam HJ, Martin I, et al
    PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
    J Antimicrob Chemother. 2022 Feb 10. pii: 6525856. doi: 10.1093.
    PubMed     Abstract available


  45. XU C, Wang N, Li D, Schwarz S, et al
    Recombination events that occur in a poxtA-carrying Enterococcus faecium during the conjugation process.
    J Antimicrob Chemother. 2022 Feb 8. pii: 6524123. doi: 10.1093.
    PubMed     Abstract available


  46. COCCITTO SN, Cinthi M, Fioriti S, Morroni G, et al
    Linezolid-resistant Enterococcus gallinarum isolate of swine origin carrying cfr, optrA and poxtA genes.
    J Antimicrob Chemother. 2022;77:331-337.
    PubMed     Abstract available


  47. MARR I, Swe K, Henderson A, Lacey JA, et al
    Cefazolin susceptibility of coagulase-negative staphylococci (CoNS) causing late-onset neonatal bacteraemia.
    J Antimicrob Chemother. 2022;77:338-344.
    PubMed     Abstract available


  48. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2022;77:320-330.
    PubMed     Abstract available


  49. WASSERMAN S, Brust JCM, Abdelwahab MT, Little F, et al
    Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study.
    J Antimicrob Chemother. 2022 Feb 2. pii: 6520540. doi: 10.1093.
    PubMed     Abstract available


  50. SCHUSTER CF, Weber RE, Weig M, Werner G, et al
    Ultra-deep long-read sequencing detects IS-mediated gene duplications as a potential trigger to generate arrays of resistance genes and a mechanism to induce novel gene variants such as blaCTX-M-243.
    J Antimicrob Chemother. 2022;77:381-390.
    PubMed     Abstract available


  51. GUO CG, Jiang F, Cheung KS, Li B, et al
    Timing of prior exposure to antibiotics and failure of Helicobacter pylori eradication: a population-based study.
    J Antimicrob Chemother. 2022;77:517-523.
    PubMed     Abstract available


  52. KANESAKA I, Ohno A, Katsuse AK, Takahashi H, et al
    The emergence of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone by transfer of resistance from an oral Neisseria subflava reservoir of resistance.
    J Antimicrob Chemother. 2022;77:364-373.
    PubMed     Abstract available


  53. LIN EY, Adamson PC, Klausner JD
    Applying molecular algorithms to predict decreased susceptibility to ceftriaxone from a report of strains of Neisseria gonorrhoeae in Amsterdam, the Netherlands.
    J Antimicrob Chemother. 2022;77:534-536.
    PubMed    


    January 2022
  54. AMBROSE SJ, Evans BA, Hall RM
    Origin of the oxa235 carbapenem resistance gene found in transposon Tn6252.
    J Antimicrob Chemother. 2022 Jan 30. pii: 6517523. doi: 10.1093.
    PubMed    


  55. KIESWETTER NS, Ozturk M, Hlaka L, Chia JE, et al
    Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515318. doi: 10.1093.
    PubMed     Abstract available


  56. ZOU G, Matuszewska M, Bai F, Wang S, et al
    Genomic analyses of Staphylococcus aureus isolated from yaks in Ganzi Tibetan Autonomous Prefecture, China.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515324. doi: 10.1093.
    PubMed     Abstract available


  57. FRENK S, Temkin E, Lurie-Weinberger MN, Keren-Paz A, et al
    Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515327. doi: 10.1093.
    PubMed     Abstract available


  58. SEMPERE J, Gonzalez-Camacho F, Domenech M, Llamosi M, et al
    A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004-20 in Spain.
    J Antimicrob Chemother. 2022 Jan 19. pii: 6511705. doi: 10.1093.
    PubMed     Abstract available


  59. PAUNKOV A, Gutenbrunner K, Soki J, Leitsch D, et al
    Haemin deprivation renders Bacteroides fragilis hypersusceptible to metronidazole and cancels high-level metronidazole resistance.
    J Antimicrob Chemother. 2022 Jan 18. pii: 6510936. doi: 10.1093.
    PubMed     Abstract available


  60. MANTZOURANI E, Cannings-John R, Evans A, Ahmed H, et al
    To swab or not to swab? Using point-of-care tests to detect Group A Streptococcus infections as part of a Sore Throat Test and Treat service in community pharmacy.
    J Antimicrob Chemother. 2022 Jan 17. pii: 6509366. doi: 10.1093.
    PubMed     Abstract available


  61. GWEE A, Duffull SB, Daley AJ, Lim M, et al
    Identifying a therapeutic target for vancomycin against staphylococci in young infants.
    J Antimicrob Chemother. 2022 Jan 17. pii: 6509364. doi: 10.1093.
    PubMed     Abstract available


  62. THILL P, Robineau O, Roosen G, Patoz P, et al
    Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infections.
    J Antimicrob Chemother. 2022 Jan 13. pii: 6506691. doi: 10.1093.
    PubMed     Abstract available


  63. GAILLARD T, Dupieux-Chabert C, Butin M, Dumitrescu O, et al
    Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure.
    J Antimicrob Chemother. 2022 Jan 11. pii: 6503862. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  64. KLAUKE P, Schwab F, Gastmeier P, Maechler F, et al
    The impact of non-antimicrobial drug agents on the acquisition of ESBL-producing Enterobacterales in non-critical care wards in a German university hospital: an exploratory, matched case-control study.
    J Antimicrob Chemother. 2021;77:229-236.
    PubMed     Abstract available


  65. FISCHER N, Maex M, Mattheus W, Van den Bossche A, et al
    Genomic epidemiology of persistently circulating MDR Shigella sonnei strains associated with men who have sex with men (MSM) in Belgium (2013-19).
    J Antimicrob Chemother. 2021;77:89-97.
    PubMed     Abstract available


  66. TIMMERMANS M, Bogaerts B, Vanneste K, De Keersmaecker SCJ, et al
    Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019.
    J Antimicrob Chemother. 2021;77:49-57.
    PubMed     Abstract available


  67. DE CARVALHO CCCR, Taglialegna A, Rosato AE
    Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated beta-lactam sensitization in clinical MRSA strains.
    J Antimicrob Chemother. 2021;77:135-147.
    PubMed     Abstract available


  68. YOON EJ, Kim HS, Woo H, Choi YJ, et al
    Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection.
    J Antimicrob Chemother. 2021;77:69-73.
    PubMed     Abstract available


  69. BAE M, Jeong Y, Bae S, Kim MJ, et al
    Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study.
    J Antimicrob Chemother. 2021;77:223-228.
    PubMed     Abstract available


  70. BUCKLEY AM, Moura IB, Altringham J, Ewin D, et al
    The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection.
    J Antimicrob Chemother. 2021;77:148-154.
    PubMed     Abstract available


  71. CAMERON-MCDERMOTT SM, Barrow GJ, Webster AM, De La Haye CO, et al
    Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19.
    J Antimicrob Chemother. 2021;77:218-222.
    PubMed     Abstract available


  72. WILLEMS RPJ, van Dijk K, Dierikx CM, Twisk JWR, et al
    Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study.
    J Antimicrob Chemother. 2021;77:237-245.
    PubMed     Abstract available


  73. STEMLER J, Lackner M, Chen SC, Hoenigl M, et al
    EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence.
    J Antimicrob Chemother. 2021;77:253-258.
    PubMed     Abstract available


  74. NURJADI D, Klein S, Hannesen J, Heeg K, et al
    Molecular analysis of an increase in trimethoprim/sulfamethoxazole-resistant MRSA reveals multiple introductions into a tertiary care hospital, Germany 2012-19.
    J Antimicrob Chemother. 2021;77:38-48.
    PubMed     Abstract available


  75. JIAN Y, Li T, Zhao L, Zhao N, et al
    Regulation of bla system in ST59-related oxacillin-susceptible mecA-positive Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Dec 16. pii: 6464066. doi: 10.1093.
    PubMed     Abstract available


  76. CINTHI M, Coccitto SN, Fioriti S, Morroni G, et al
    Occurrence of a plasmid co-carrying cfr(D) and poxtA2 linezolid resistance genes in Enterococcus faecalis and Enterococcus casseliflavus from porcine manure, Italy.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6463073. doi: 10.1093.
    PubMed     Abstract available


  77. SHANG Y, Lv P, Su D, Li Y, et al
    Evolutionary conservative analysis revealed novel functional sites in the efflux pump NorA of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6463078. doi: 10.1093.
    PubMed     Abstract available


  78. PIRES J, Huisman JS, Bonhoeffer S, Van Boeckel TP, et al
    Increase in antimicrobial resistance in Escherichia coli in food animals between 1980 and 2018 assessed using genomes from public databases.
    J Antimicrob Chemother. 2021 Dec 11. pii: 6459599. doi: 10.1093.
    PubMed     Abstract available


  79. HOLLAND M, Bjanes E, Nizet V, Dillon N, et al
    Bicarbonate modulates delafloxacin activity against MDR Staphylococcus aureus and Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2021 Dec 10. pii: 6459101. doi: 10.1093.
    PubMed     Abstract available


  80. CEBALLOS-GARZON A, Monteoliva L, Gil C, Alvarez-Moreno C, et al
    Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.
    J Antimicrob Chemother. 2021 Dec 10. pii: 6459103. doi: 10.1093.
    PubMed     Abstract available


  81. DIAZ-DIAZ S, Recacha E, Garcia-Duque A, Docobo-Perez F, et al
    Effect of RecA inactivation and detoxification systems on the evolution of ciprofloxacin resistance in Escherichia coli.
    J Antimicrob Chemother. 2021 Dec 8. pii: 6456190. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  82. CHEUNG CY, McNeil MB, Cook GM
    Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of Mycobacterium tuberculosis infection.
    J Antimicrob Chemother. 2021 Nov 28. pii: 6445137. doi: 10.1093.
    PubMed     Abstract available


  83. COCCITTO SN, Cinthi M, Fioriti S, Morroni G, et al
    Linezolid-resistant Enterococcus gallinarum isolate of swine origin carrying cfr, optrA and poxtA genes.
    J Antimicrob Chemother. 2021 Nov 23. pii: 6433473. doi: 10.1093.
    PubMed     Abstract available


  84. WILCOX MH, Dryden M
    Update on the epidemiology of healthcare-acquired bacterial infections: focus on complicated skin and skin structure infections.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  85. MARR I, Swe K, Henderson A, Lacey JA, et al
    Cefazolin susceptibility of coagulase-negative staphylococci (CoNS) causing late-onset neonatal bacteraemia.
    J Antimicrob Chemother. 2021 Nov 13. pii: 6427455. doi: 10.1093.
    PubMed     Abstract available


  86. MYLONA E, Voong Vinh P, Qureshi S, Karkey A, et al
    Tebipenem as an oral alternative for the treatment of typhoid caused by XDR Salmonella Typhi.
    J Antimicrob Chemother. 2021;76:3197-3200.
    PubMed     Abstract available


  87. AL-MIR H, Osman M, Drapeau A, Hamze M, et al
    Spread of ESC-, carbapenem- and colistin-resistant Escherichia coli clones and plasmids within and between food workers in Lebanon.
    J Antimicrob Chemother. 2021;76:3135-3143.
    PubMed     Abstract available


  88. ZHANG S, Liu P, Wang Y, Shen Z, et al
    Multiresistance gene cfr(C) in Clostridium perfringens of cattle origin from China.
    J Antimicrob Chemother. 2021;76:3310-3312.
    PubMed    


  89. BOOSTROM I, Bala Y, Vasic JM, Gluvakov J, et al
    Evaluation of the MYCOPLASMA IST3 urogenital mycoplasma assay in an international multicentre trial.
    J Antimicrob Chemother. 2021;76:3175-3182.
    PubMed     Abstract available


  90. LO FWY, Kong FYS, Hocking JS
    Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials.
    J Antimicrob Chemother. 2021;76:3111-3124.
    PubMed     Abstract available


  91. SHASKOLSKIY B, Kandinov I, Kravtsov D, Filippova M, et al
    Prediction of ceftriaxone MIC in Neisseria gonorrhoeae using DNA microarray technology and regression analysis.
    J Antimicrob Chemother. 2021;76:3151-3158.
    PubMed     Abstract available


  92. HEARD F, Sehgal A
    Vancomycin in adult prescribing: is it time to move on from trough-based dosing in the UK?
    J Antimicrob Chemother. 2021;76:3071-3072.
    PubMed     Abstract available


  93. RAUWOLF KK, Hoertnagl C, Lass-Floerl C, Groll AH, et al
    Interaction in vitro of pulmonary surfactant with antifungal agents used for treatment and prevention of invasive aspergillosis.
    J Antimicrob Chemother. 2021 Nov 11. pii: 6425642. doi: 10.1093.
    PubMed     Abstract available


  94. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423109. doi: 10.1093.
    PubMed     Abstract available


  95. TANG N, Hu J, Zhao Y, Song Y, et al
    In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment.
    J Antimicrob Chemother. 2021 Nov 2. pii: 6415960. doi: 10.1093.
    PubMed    


    October 2021
  96. PRATAMA R, Beukers AG, McIver CJ, Keighley CL, et al
    A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event.
    J Antimicrob Chemother. 2021 Oct 29. pii: 6414308. doi: 10.1093.
    PubMed     Abstract available


  97. JEN FE, El-Deeb IM, Zalucki YM, Edwards JL, et al
    A drug candidate for Alzheimer's and Huntington's disease, PBT2, can be repurposed to render Neisseria gonorrhoeae susceptible to natural cationic antimicrobial peptides.
    J Antimicrob Chemother. 2021;76:2850-2853.
    PubMed     Abstract available


  98. BORTOLAIA V, Ronco T, Romascu L, Nicorescu I, et al
    Co-localization of carbapenem (blaOXA-162) and colistin (mcr-1) resistance genes on a transferable IncHI2 plasmid in Escherichia coli of chicken origin.
    J Antimicrob Chemother. 2021;76:3063-3065.
    PubMed    


  99. ADACHI F, Sekizuka T, Yamato M, Fukuoka K, et al
    Characterization of FRI carbapenemase-producing Enterobacter spp. isolated from a hospital and the environment in Osaka, Japan.
    J Antimicrob Chemother. 2021;76:3061-3062.
    PubMed    


  100. GOLDEN AR, Karlowsky JA, Walkty A, Baxter MR, et al
    Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
    J Antimicrob Chemother. 2021;76:2825-2832.
    PubMed     Abstract available


  101. KARLOWSKY JA, Walkty A, Golden AR, Baxter MR, et al
    ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
    J Antimicrob Chemother. 2021;76:2815-2824.
    PubMed     Abstract available


  102. ZAHR N, Urien S, Aubry A, Chauvin C, et al
    Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infections.
    J Antimicrob Chemother. 2021;76:2906-2913.
    PubMed     Abstract available


  103. RING K, Shiva F
    Comment on: Clinical and serological outcomes in patients treated with oral doxycycline for early neurosyphilis.
    J Antimicrob Chemother. 2021;76:3067-3068.
    PubMed    


  104. ADAMSON PC, Lin EY, Ha SM, Klausner JD, et al
    Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance.
    J Antimicrob Chemother. 2021;76:2847-2849.
    PubMed     Abstract available


  105. GOLDSTEIN E
    Rise in the prevalence of resistance to extended-spectrum cephalosporins in the USA, nursing homes and antibiotic prescribing in outpatient and inpatient settings.
    J Antimicrob Chemother. 2021;76:2745-2747.
    PubMed     Abstract available


  106. CHARRET L, Bart G, Hoppe E, Dernis E, et al
    Clinical characteristics and management of olecranon and prepatellar septic bursitis in a multicentre study.
    J Antimicrob Chemother. 2021;76:3029-3032.
    PubMed     Abstract available


    September 2021
  107. ENGBERG J, Vejrum LK, Madsen TV, Nielsen XC, et al
    Verification of analytical bacterial spectrum of QIAstat-Dx(R) GI V2 and Novodiag(R) Bacterial GE+ V2-0 diagnostic panels.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  108. ZHANG X, Wang L, Li D, Wang C, et al
    Characterization of the novel plasmid-encoded MBL gene blaAFM-1, integrated into a blaIMP-45-bearing transposon Tn6485e in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2021 Sep 17. pii: 6371932. doi: 10.1093.
    PubMed     Abstract available


  109. CHEN LF, Wang TC, Chen FL, Hsu SC, et al
    Efficacy of doxycycline versus azithromycin for the treatment of rectal chlamydia: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2021 Sep 16. pii: 6371309. doi: 10.1093.
    PubMed     Abstract available


  110. DIEZ-AGUILAR M, Ekkelenkamp M, Morosini MI, Huertas N, et al
    Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates.
    J Antimicrob Chemother. 2021;76:2578-2585.
    PubMed     Abstract available


  111. SASS G, Larwood DJ, Martinez M, Shrestha P, et al
    Efficacy of nikkomycin Z in murine CNS coccidioidomycosis: modelling sustained-release dosing.
    J Antimicrob Chemother. 2021;76:2629-2635.
    PubMed     Abstract available


  112. GEBREMARIAM T, Gu Y, Singh S, Kitt TM, et al
    Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis.
    J Antimicrob Chemother. 2021;76:2636-2639.
    PubMed     Abstract available


  113. DARAGON B, Fournier D, Plesiat P, Jeannot K, et al
    Performance of disc diffusion, MIC gradient tests and Vitek 2 for ceftolozane/tazobactam and ceftazidime/avibactam susceptibility testing of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2021;76:2586-2592.
    PubMed     Abstract available


  114. PALACE SG, Fryling KE, Li Y, Wentworth AJ, et al
    Identification of bile acid and fatty acid species as candidate rapidly bactericidal agents for topical treatment of gonorrhoea.
    J Antimicrob Chemother. 2021;76:2569-2577.
    PubMed     Abstract available


  115. ROYER G, Poirel L, La Combe B, Clermont O, et al
    Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:2736-2737.
    PubMed    


  116. MAMA OM, Aspiroz C, Lozano C, Ruiz-Ripa L, et al
    Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.
    J Antimicrob Chemother. 2021;76:2519-2527.
    PubMed     Abstract available


  117. RAISANEN K, Sarvikivi E, Arifulla D, Pietikainen R, et al
    Three clusters of carbapenemase-producing Citrobacter freundii in Finland, 2016-20.
    J Antimicrob Chemother. 2021;76:2697-2701.
    PubMed     Abstract available


  118. BIEDRZYCKA M, Urbanowicz P, Guzek A, Brisse S, et al
    Dissemination of Klebsiella pneumoniae ST147 NDM-1 in Poland, 2015-19.
    J Antimicrob Chemother. 2021;76:2538-2545.
    PubMed     Abstract available


  119. SLAVIN MA, Chen YC, Cordonnier C, Cornely OA, et al
    When to change treatment of acute invasive aspergillosis: an expert viewpoint.
    J Antimicrob Chemother. 2021 Sep 11. pii: 6368907. doi: 10.1093.
    PubMed     Abstract available


  120. FLATEAU C, Riazi A, Cassard B, Camus M, et al
    Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?
    J Antimicrob Chemother. 2021 Sep 6. pii: 6364850. doi: 10.1093.
    PubMed     Abstract available


  121. ABE R, Oyama F, Akeda Y, Nozaki M, et al
    Hospital-wide outbreaks of carbapenem-resistant Enterobacteriaceae horizontally spread through a clonal plasmid harbouring blaIMP-1 in children's hospitals in Japan.
    J Antimicrob Chemother. 2021 Sep 3. pii: 6363635. doi: 10.1093.
    PubMed    


  122. ABBOTT IJ, Mouton JW, Peleg AY, Meletiadis J, et al
    Pharmacokinetic/pharmacodynamic analysis of oral fosfomycin against Enterobacterales, Pseudomonas aeruginosa and Enterococcus spp. in an in vitro bladder infection model: impact on clinical breakpoints.
    J Antimicrob Chemother. 2021 Sep 2. pii: 6362682. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  123. MARRO FC, Abad L, Blocker AJ, Laurent F, et al
    In vitro antibiotic activity against intraosteoblastic Staphylococcus aureus: a narrative review of the literature.
    J Antimicrob Chemother. 2021 Aug 30. pii: 6359549. doi: 10.1093.
    PubMed     Abstract available


  124. TEDIM AP, Lanza VF, Rodriguez CM, Freitas AR, et al
    Fitness cost of vancomycin-resistant Enterococcus faecium plasmids associated with hospital infection outbreaks.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358700. doi: 10.1093.
    PubMed     Abstract available


  125. COUPRI D, Verneuil N, Hartke A, Liebaut A, et al
    Inhibition of d-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358701. doi: 10.1093.
    PubMed     Abstract available


  126. MOUNSEY O, Schubert H, Findlay J, Morley K, et al
    Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358704. doi: 10.1093.
    PubMed     Abstract available


  127. CHAUVELOT P, Dupieux-Chabert C, Abad L, Souche A, et al
    Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection.
    J Antimicrob Chemother. 2021 Aug 23. pii: 6356267. doi: 10.1093.
    PubMed     Abstract available


  128. ZHU Y, Yang Q, Schwarz S, Yang W, et al
    Identification of a Streptococcus parasuis isolate co-harbouring the oxazolidinone resistance genes cfr(D) and optrA.
    J Antimicrob Chemother. 2021 Aug 18. pii: 6354200. doi: 10.1093.
    PubMed    


  129. URBANOWICZ P, Izdebski R, Baraniak A, Zabicka D, et al
    Molecular and genomic epidemiology of VIM/IMP-like metallo-beta-lactamase-producing Pseudomonas aeruginosa genotypes in Poland.
    J Antimicrob Chemother. 2021;76:2273-2284.
    PubMed     Abstract available


  130. TYDEMAN F, Craine N, Kavanagh K, Adams H, et al
    Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales.
    J Antimicrob Chemother. 2021;76:2437-2445.
    PubMed     Abstract available


  131. MUNTEAN MM, Muntean AA, Guerin F, Cattoir V, et al
    Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers.
    J Antimicrob Chemother. 2021;76:2294-2301.
    PubMed     Abstract available


  132. SIX A, Mosbahi K, Barge M, Kleanthous C, et al
    Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis.
    J Antimicrob Chemother. 2021;76:2317-2324.
    PubMed     Abstract available


  133. LI R, Peng K, Xiao X, Wang Y, et al
    Characterization of novel ISAba1-bounded tet(X15)-bearing composite transposon Tn6866 in Acinetobacter variabilis.
    J Antimicrob Chemother. 2021;76:2481-2483.
    PubMed    


  134. VADLAMUDI NK, Saatchi A, Patrick DM, Rose C, et al
    Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, Canada.
    J Antimicrob Chemother. 2021;76:2419-2427.
    PubMed     Abstract available


  135. MACVANE SH, Bhalodi AA, Dare RK, Rosenbaum ER, et al
    Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest BC Kit.
    J Antimicrob Chemother. 2021;76:2453-2463.
    PubMed     Abstract available


  136. COCCITTO SN, Fioriti S, Cinthi M, Morroni G, et al
    Detection of phenicol-oxazolidinone resistance gene optrA in Aerococcus viridans from bovine faeces, Italy.
    J Antimicrob Chemother. 2021;76:2479-2481.
    PubMed    


  137. KUMAR M, Mathur T, Barman TK, Chaira T, et al
    Novel FtsZ inhibitor with potent activity against Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Aug 11. pii: 6350072. doi: 10.1093.
    PubMed     Abstract available


  138. GITMAN MR, Alburquerque B, Chung M, van de Guchte A, et al
    Modified methicillin-resistant Staphylococcus aureus detected in neonatal intensive care patients.
    J Antimicrob Chemother. 2021 Aug 9. pii: 6345863. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  139. VERSPORTEN A, Bruyndonckx R, Adriaenssens N, Hens N, et al
    Consumption of cephalosporins in the community, European Union/European Economic Area, 1997-2017.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  140. BRUYNDONCKX R, Adriaenssens N, Versporten A, Hens N, et al
    Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  141. ADRIAENSSENS N, Bruyndonckx R, Versporten A, Hens N, et al
    Consumption of quinolones in the community, European Union/European Economic Area, 1997-2017.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  142. LIU P, Hao Z, Liu M, Niu M, et al
    Genetic mutations in adaptive evolution of growth-independent vancomycin-tolerant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jul 23. pii: 6327451. doi: 10.1093.
    PubMed     Abstract available


  143. LUCENA NEMIROSKY J, Espelt R, Lopez Grado E, Sobrino J, et al
    Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study.
    J Antimicrob Chemother. 2021 Jul 19. pii: 6323546. doi: 10.1093.
    PubMed     Abstract available


  144. STOSIC MS, Leangapichart T, Lunha K, Jiwakanon J, et al
    Novel mcr-3.40 variant co-located with mcr-2.3 and blaCTX-M-63 on an IncHI1B/IncFIB plasmid found in Klebsiella pneumoniae from a healthy carrier in Thailand.
    J Antimicrob Chemother. 2021;76:2218-2220.
    PubMed    


  145. BABICH T, Naucler P, Valik JK, Giske CG, et al
    Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.
    J Antimicrob Chemother. 2021;76:2172-2181.
    PubMed     Abstract available


  146. SCHECHNER V, Fallach N, Braun T, Temkin E, et al
    Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study.
    J Antimicrob Chemother. 2021;76:2182-2185.
    PubMed     Abstract available


  147. TROTT DJ, Turnidge J, Kovac JH, Simjee S, et al
    Comparative macrolide use in humans and animals: should macrolides be moved off the World Health Organisation's critically important antimicrobial list?
    J Antimicrob Chemother. 2021;76:1955-1961.
    PubMed     Abstract available


  148. PANTEL A, Nachar O, Boudet A, Loubet P, et al
    In vitro activity of dalbavancin against Gram-positive bacteria isolated from diabetic foot osteomyelitis.
    J Antimicrob Chemother. 2021;76:2057-2060.
    PubMed     Abstract available


  149. MCMURTRY TA, Barekat A, Rodriguez F, Purewal P, et al
    Capability of Enterococcus faecalis to shield Gram-negative pathogens from aminoglycoside exposure.
    J Antimicrob Chemother. 2021 Jul 10. pii: 6318623. doi: 10.1093.
    PubMed     Abstract available


  150. ASEMPA TE, DeRosa NA, Cassino C, Lehoux D, et al
    Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model.
    J Antimicrob Chemother. 2021 Jul 5. pii: 6314896. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  151. KRUGER H, Ji X, Wang Y, Fessler AT, et al
    Identification of Tn553, a novel Tn554-related transposon that carries a complete blaZ-blaR1-blaI beta-lactamase operon in Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 24. pii: 6308652. doi: 10.1093.
    PubMed    


  152. SATISHKUMAR N, Alexander JAN, Poon R, Buggeln E, et al
    PBP4-mediated beta-lactam resistance among clinical strains of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307153. doi: 10.1093.
    PubMed     Abstract available


  153. PINHOLT M, Mollerup S, Boye K, Worning P, et al
    Investigation of the introduction and dissemination of vanB Enterococcus faecium in the Capital Region of Denmark and development of a rapid and accurate clone-specific vanB E. faecium PCR.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6306968. doi: 10.1093.
    PubMed     Abstract available


  154. HANAO M, Aoki K, Ishii Y, Shimuta K, et al
    Molecular characterization of Neisseria gonorrhoeae isolates collected through a national surveillance programme in Japan, 2013: evidence of the emergence of a ceftriaxone-resistant strain from a ceftriaxone-susceptible lineage.
    J Antimicrob Chemother. 2021;76:1769-1775.
    PubMed     Abstract available


  155. NOBREGA DE ALMEIDA J, Francisco EC, Holguin Ruiz A, Cuellar LE, et al
    Epidemiology, clinical aspects, outcomes and prognostic factors associated with Trichosporon fungaemia: results of an international multicentre study carried out at 23 medical centres.
    J Antimicrob Chemother. 2021;76:1907-1915.
    PubMed     Abstract available


  156. ZHANEL GG, Adam HJ, Baxter M, Lagace-Wiens PRS, et al
    In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
    J Antimicrob Chemother. 2021;76:1808-1814.
    PubMed     Abstract available


  157. SIERRA Y, Gonzalez-Diaz A, Carrera-Salinas A, Berbel D, et al
    Genome-wide analysis of urogenital and respiratory multidrug-resistant Haemophilus parainfluenzae.
    J Antimicrob Chemother. 2021;76:1741-1751.
    PubMed     Abstract available


  158. SLIMINGS C, Riley TV
    Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.
    J Antimicrob Chemother. 2021;76:1676-1688.
    PubMed     Abstract available


  159. DE KORNE-ELENBAAS J, Bruisten SM, de Vries HJC, Van Dam AP, et al
    Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis.
    J Antimicrob Chemother. 2021;76:1759-1768.
    PubMed     Abstract available


  160. LE TURNIER P, El Helali N, Guilhaumou R, Pilmis B, et al
    CSF concentration of cefotaxime in adult patients with pneumococcal meningitis: a multicentre retrospective study.
    J Antimicrob Chemother. 2021 Jun 13. pii: 6297842. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  161. BERBEL D, Camara J, Gonzalez-Diaz A, Cubero M, et al
    Deciphering mobile genetic elements disseminating macrolide resistance in Streptococcus pyogenes over a 21 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2021 May 20. pii: 6279207. doi: 10.1093.
    PubMed     Abstract available


  162. SABAT AJ, Bathoorn E, Becker K, Akkerboom V, et al
    Staphylococcal cassette chromosome mec containing a novel mec gene complex, B4.
    J Antimicrob Chemother. 2021 May 15. pii: 6276546. doi: 10.1093.
    PubMed     Abstract available


  163. SUGAWARA Y, Hagiya H, Akeda Y, Takeuchi D, et al
    Community spread and acquisition of clinically relevant Escherichia coli harbouring blaNDM among healthy Japanese residents of Yangon, Myanmar.
    J Antimicrob Chemother. 2021;76:1448-1454.
    PubMed     Abstract available


  164. GALARION LH, Mohamad M, Alzeyadi Z, Randall CP, et al
    A platform for detecting cross-resistance in antibacterial drug discovery.
    J Antimicrob Chemother. 2021;76:1467-1471.
    PubMed     Abstract available


  165. FRISCH S, Boese A, Huck B, Horstmann JC, et al
    A pulmonary mucus surrogate for investigating antibiotic permeation and activity against Pseudomonas aeruginosa biofilms.
    J Antimicrob Chemother. 2021;76:1472-1479.
    PubMed     Abstract available


  166. NAIR S, Chattaway M, Langridge GC, Gentle A, et al
    ESBL-producing strains isolated from imported cases of enteric fever in England and Wales reveal multiple chromosomal integrations of blaCTX-M-15 in XDR Salmonella Typhi.
    J Antimicrob Chemother. 2021;76:1459-1466.
    PubMed     Abstract available


  167. VAN KLEEF E, Wielders CCH, Schouls LM, Feenstra SG, et al
    National point prevalence study on carriage of multidrug-resistant microorganisms in Dutch long-term care facilities in 2018.
    J Antimicrob Chemother. 2021;76:1604-1613.
    PubMed     Abstract available


  168. BRANDIS G, Gockel J, Garoff L, Guy L, et al
    Expression of the qepA1 gene is induced under antibiotic exposure.
    J Antimicrob Chemother. 2021;76:1433-1440.
    PubMed     Abstract available


  169. KARCZEWSKI J, Brown CM, Maezato Y, Krasucki SP, et al
    Efficacy of a novel lantibiotic, CMB001, against MRSA.
    J Antimicrob Chemother. 2021;76:1532-1538.
    PubMed     Abstract available


  170. PARSELS KA, Mastro KA, Steele JM, Thomas SJ, et al
    Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections.
    J Antimicrob Chemother. 2021;76:1379-1391.
    PubMed     Abstract available


  171. BRIGGS S, Broom M, Duffy E, Everts R, et al
    Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis.
    J Antimicrob Chemother. 2021 May 11. pii: 6274254. doi: 10.1093.
    PubMed     Abstract available


  172. NOEL AR, Attwood M, Bowker KE, MacGowan AP, et al
    The pharmacodynamics of minocycline alone and in combination with rifampicin against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.
    J Antimicrob Chemother. 2021 May 11. pii: 6274253. doi: 10.1093.
    PubMed     Abstract available


  173. ADAMECZ Z, Nielsen KL, Kirkby NS, Frimodt-Moller N, et al
    Aminoglycoside resistance genes in Enterococcus faecium: mismatch with phenotype.
    J Antimicrob Chemother. 2021 May 9. pii: 6272857. doi: 10.1093.
    PubMed    


  174. WANG W, Sun B
    VraCP regulates cell wall metabolism and antibiotic resistance in vancomycin-intermediate Staphylococcus aureus strain Mu50.
    J Antimicrob Chemother. 2021 May 5. pii: 6264898. doi: 10.1093.
    PubMed     Abstract available


  175. HAO M, Schuyler J, Zhang H, Shashkina E, et al
    Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains.
    J Antimicrob Chemother. 2021 May 3. pii: 6263424. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  176. DEJOIES L, Sassi M, Schutz S, Moreaux J, et al
    Genetic features of the poxtA linezolid resistance gene in human enterococci from France.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6251856. doi: 10.1093.
    PubMed     Abstract available


  177. PUTSATHIT P, Hong S, George N, Hemphill C, et al
    Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6250920. doi: 10.1093.
    PubMed     Abstract available


  178. BOEKHOUD IM, Sidorov I, Nooij S, Harmanus C, et al
    Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Apr 20. pii: 6239454. doi: 10.1093.
    PubMed     Abstract available


  179. NI W, Yang D, Guan J, Xi W, et al
    In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226986. doi: 10.1093.
    PubMed     Abstract available


  180. WALKER SV, Wolke M, Plum G, Weber RE, et al
    Failure of Vitek2 to reliably detect vanB-mediated vancomycin resistance in Enterococcus faecium.
    J Antimicrob Chemother. 2021 Apr 14. pii: 6225960. doi: 10.1093.
    PubMed     Abstract available


  181. LU CH, Shiau CW, Chang YC, Kung HN, et al
    SC5005 dissipates the membrane potential to kill Staphylococcus aureus persisters without detectable resistance.
    J Antimicrob Chemother. 2021 Apr 14. pii: 6225957. doi: 10.1093.
    PubMed     Abstract available


  182. MASON CY, Kanitkar T, Richardson CJ, Lanzman M, et al
    Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics.
    J Antimicrob Chemother. 2021;76:1323-1331.
    PubMed     Abstract available


  183. BRILHANTE M, Gobeli Brawand S, Endimiani A, Rohrbach H, et al
    Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral hospital.
    J Antimicrob Chemother. 2021;76:1140-1149.
    PubMed     Abstract available


  184. UNEMO M, Ahlstrand J, Sanchez-Buso L, Day M, et al
    High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
    J Antimicrob Chemother. 2021;76:1221-1228.
    PubMed     Abstract available


  185. NOBREGA D, Peirano G, Lynch T, Finn TJ, et al
    Spatial distribution of Escherichia coli ST131 C subclades in a centralized Canadian urban region.
    J Antimicrob Chemother. 2021;76:1135-1139.
    PubMed     Abstract available


  186. MARIN JEO, Villatoro E, Luna MJ, Barrientos AM, et al
    Emergence of MDR invasive Neisseria meningitidis in El Salvador, 2017-19.
    J Antimicrob Chemother. 2021;76:1155-1159.
    PubMed     Abstract available


  187. LEE IR, Thein TL, Ang LW, Ding Y, et al
    Cefazolin versus ceftriaxone as definitive treatment for Klebsiella pneumoniae bacteraemia: a retrospective multicentre study in Singapore.
    J Antimicrob Chemother. 2021;76:1303-1310.
    PubMed     Abstract available


  188. FIFER H, Livermore DM, Uthayakumaran T, Woodford N, et al
    What's left in the cupboard? Older antimicrobials for treating gonorrhoea.
    J Antimicrob Chemother. 2021;76:1215-1220.
    PubMed     Abstract available


  189. PAI MP, Wilcox MH, Chitra S, McGovern PC, et al
    Safety and efficacy of omadacycline by BMI categories and diabetes history in two Phase III randomized studies of patients with acute bacterial skin and skin structure infections.
    J Antimicrob Chemother. 2021;76:1315-1322.
    PubMed     Abstract available


  190. MARIMUTHU K, Mo Y, Ling ML, Hernandez-Koutoucheva A, et al
    Household transmission of carbapenemase-producing Enterobacteriaceae: a prospective cohort study.
    J Antimicrob Chemother. 2021;76:1299-1302.
    PubMed     Abstract available


  191. CASTANEDA X, Garcia-De-la-Maria C, Gasch O, Pericas JM, et al
    Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocardit
    J Antimicrob Chemother. 2021 Apr 9. pii: 6219388. doi: 10.1093.
    PubMed     Abstract available


  192. MOSER S, Rehm S, Guertler N, Hinic V, et al
    Probability of pharmacological target attainment with flucloxacillin in Staphylococcus aureus bloodstream infection: a prospective cohort study of unbound plasma and individual MICs.
    J Antimicrob Chemother. 2021 Apr 8. pii: 6227026. doi: 10.1093.
    PubMed     Abstract available


  193. LEANGAPICHART T, Lunha K, Jiwakanon J, Angkititrakul S, et al
    Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes.
    J Antimicrob Chemother. 2021 Apr 8. pii: 6215053. doi: 10.1093.
    PubMed     Abstract available


  194. JIANG N, Wyres KL, Li J, Fessler AT, et al
    Evolution and genomic insight into methicillin-resistant Staphylococcus aureus ST9 in China.
    J Antimicrob Chemother. 2021 Apr 5. pii: 6210593. doi: 10.1093.
    PubMed     Abstract available


  195. CHEN YH, Lin SY, Lin YT, Tseng SP, et al
    Emergence of aac(6')-Ie-aph(2'')-Ia-positive enterococci with non-high-level gentamicin resistance mediated by IS1216V: adaptation to decreased aminoglycoside usage in Taiwan.
    J Antimicrob Chemother. 2021 Apr 2. pii: 6208785. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  196. BRUSAMARELLO C, Daley AJ, Zhu X, Landersdorfer C, et al
    How important are MIC determination methods when targeting vancomycin levels in patients with Staphylococcus aureus infections?
    J Antimicrob Chemother. 2021 Mar 18. pii: 6177478. doi: 10.1093.
    PubMed    


  197. FALCONE M, Tiseo G, Giordano C, Leonildi A, et al
    Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.
    J Antimicrob Chemother. 2021;76:1078-1084.
    PubMed     Abstract available


  198. NURNBERG S, Claus H, Krone M, Vogel U, et al
    Cefotaxime resistance in invasive Haemophilus influenzae isolates in Germany 2016-19: prevalence, epidemiology and relevance of PBP3 substitutions.
    J Antimicrob Chemother. 2021;76:920-929.
    PubMed     Abstract available


  199. VERSCHUUREN TD, van Hout D, Arredondo-Alonso S, Fluit AC, et al
    Comparative genomics of ESBL-producing Escherichia coli (ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-intestinal infection isolates in the Netherlands (2014-17).
    J Antimicrob Chemother. 2021;76:901-908.
    PubMed     Abstract available


  200. CORTAZZO V, Giordano L, D'Inzeo T, Fiori B, et al
    EUCAST rapid antimicrobial susceptibility testing of blood cultures positive for Escherichia coli or Klebsiella pneumoniae: experience of three laboratories in Italy.
    J Antimicrob Chemother. 2021;76:1110-1112.
    PubMed    


  201. YAN J, Chen Y, Yang F, Ling X, et al
    High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China.
    J Antimicrob Chemother. 2021;76:936-939.
    PubMed     Abstract available


  202. ZHENG Z, Ye L, Li R, Chen S, et al
    Whole-genome sequencing of strains of Vibrio spp. from China reveals different genetic contexts of blaCTX-M-14 among diverse lineages.
    J Antimicrob Chemother. 2021;76:950-956.
    PubMed     Abstract available


  203. SALMERON P, Moreno-Mingorance A, Trejo J, Amado R, et al
    Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016-18.
    J Antimicrob Chemother. 2021;76:930-935.
    PubMed     Abstract available


  204. AHMADI MH
    Resistance to tetracyclines among clinical isolates of Mycoplasma hominis and Ureaplasma species: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2021;76:865-875.
    PubMed     Abstract available


  205. DIEZ-AGUILAR M, Hernandez-Garcia M, Morosini MI, Fluit A, et al
    Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates.
    J Antimicrob Chemother. 2021;76:984-992.
    PubMed     Abstract available


  206. COLLINS DA, Wu Y, Tateda K, Kim HJ, et al
    Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile.
    J Antimicrob Chemother. 2021;76:967-972.
    PubMed     Abstract available


  207. LIN EY, Adamson PC, Klausner JD
    Evaluating the generalizability of a multiplex real-time PCR assay for predicting decreased susceptibility to ceftriaxone in a global set of Neisseria gonorrhoeae sequences.
    J Antimicrob Chemother. 2021;76:1104-1106.
    PubMed    


  208. CABOT G, Lara-Esbri P, Mulet X, Oliver A, et al
    Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples.
    J Antimicrob Chemother. 2021;76:945-949.
    PubMed     Abstract available


  209. CHEW KL, Octavia S, Go J, Ng S, et al
    In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimens.
    J Antimicrob Chemother. 2021;76:973-978.
    PubMed     Abstract available


  210. NUCCI M, Jenks J, Thompson GR, Hoenigl M, et al
    Do high MICs predict the outcome in invasive fusariosis?
    J Antimicrob Chemother. 2021;76:1063-1069.
    PubMed     Abstract available


  211. BENTZ ML, Nunnally N, Lockhart SR, Sexton DJ, et al
    Antifungal activity of nikkomycin Z against Candida auris.
    J Antimicrob Chemother. 2021 Mar 3. pii: 6157462. doi: 10.1093.
    PubMed     Abstract available


  212. SHANG Y, Lv P, Li S, Wang W, et al
    Allele-based analysis revealed the critical functions of region 277-297 in the NorA efflux pump of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Mar 3. pii: 6157432. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  213. FERNANDEZ-HUERTA M, Serra-Pladevall J, Pumarola T, Pich OQ, et al
    Comment on: Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2021 Feb 28. pii: 6154381. doi: 10.1093.
    PubMed    


  214. PORTAL E, Descours G, Ginevra C, Mentasti M, et al
    Legionella antibiotic susceptibility testing: is it time for international standardization and evidence-based guidance?
    J Antimicrob Chemother. 2021 Feb 20. pii: 6145330. doi: 10.1093.
    PubMed     Abstract available


  215. RACHINA S, Zakharenkov I, Dekhnich N, Kozlov R, et al
    Aetiology of severe community-acquired pneumonia and antimicrobial susceptibility of Streptococcus pneumoniae in adults in Russia.
    J Antimicrob Chemother. 2021 Feb 19. pii: 6144791. doi: 10.1093.
    PubMed    


  216. BROWN NM, Brown EM
    Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK.
    J Antimicrob Chemother. 2021 Feb 14. pii: 6134889. doi: 10.1093.
    PubMed     Abstract available


  217. WANG L, Amin AK, Khanna P, Aali A, et al
    An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London.
    J Antimicrob Chemother. 2021;76:796-803.
    PubMed     Abstract available


  218. SALMERON P, Vinado B, Arando M, Alcoceba E, et al
    Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
    J Antimicrob Chemother. 2021 Feb 11. pii: 6132746. doi: 10.1093.
    PubMed     Abstract available


  219. TAKEBAYASHI Y, Findlay J, Heesom KJ, Warburton PJ, et al
    Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) beta-lactamase enzymes in Acinetobacter baumannii.
    J Antimicrob Chemother. 2021;76:587-595.
    PubMed     Abstract available


  220. GUO S, Aung KT, Leekitcharoenphon P, Tay MYF, et al
    Prevalence and genomic analysis of ESBL-producing Escherichia coli in retail raw meats in Singapore.
    J Antimicrob Chemother. 2021;76:601-605.
    PubMed     Abstract available


  221. WOLTER DJ, Scott A, Armbruster CR, Whittington D, et al
    Repeated isolation of an antibiotic-dependent and temperature-sensitive mutant of Pseudomonas aeruginosa from a cystic fibrosis patient.
    J Antimicrob Chemother. 2021;76:616-625.
    PubMed     Abstract available


  222. KUO SC, Tan MC, Huang WC, Wu HC, et al
    Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods.
    J Antimicrob Chemother. 2021;76:653-658.
    PubMed     Abstract available


  223. SPRUTE R, Salmanton-Garcia J, Sal E, Malaj X, et al
    Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope(R) registry and literature reports.
    J Antimicrob Chemother. 2021;76:765-774.
    PubMed     Abstract available


  224. KARAISKOS I, Daikos GL, Gkoufa A, Adamis G, et al
    Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study.
    J Antimicrob Chemother. 2021;76:775-783.
    PubMed     Abstract available


  225. BALTAS I, Stockdale T, Tausan M, Kashif A, et al
    Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time.
    J Antimicrob Chemother. 2021;76:813-819.
    PubMed     Abstract available


  226. YAO H, Zhao W, Jiao D, Schwarz S, et al
    Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni.
    J Antimicrob Chemother. 2021;76:596-600.
    PubMed     Abstract available


  227. TIETGEN M, Leukert L, Sommer J, Kramer JS, et al
    Characterization of the novel OXA-213-like beta-lactamase OXA-822 from Acinetobacter calcoaceticus.
    J Antimicrob Chemother. 2021;76:626-634.
    PubMed     Abstract available


  228. COLOMBO AL, Agnelli C, Kontoyiannis DP
    Knowledge gaps in candidaemia/invasive candidiasis in haematological cancer patients.
    J Antimicrob Chemother. 2021;76:543-546.
    PubMed     Abstract available


  229. FERNANDEZ-CUENCA F, Lopez-Hernandez I, Cercenado E, Conejo C, et al
    Reporting antimicrobial susceptibilities and resistance phenotypes in Staphylococcus spp.: a nationwide proficiency study.
    J Antimicrob Chemother. 2021 Feb 8. pii: 6130710. doi: 10.1093.
    PubMed     Abstract available


  230. LE ROY C, Touati A, Balcon C, Garraud J, et al
    Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and Chlamydia trachomatis.
    J Antimicrob Chemother. 2021 Feb 4. pii: 6127604. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  231. GIANNELLA M, Bartoletti M, Conti M, Righi E, et al
    Carbapenemase-producing Enterobacteriaceae in transplant patients.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  232. TSIOUTIS C, Eichel VM, Mutters NT
    Transmission of Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: the role of infection control.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  233. CARRARA E, Conti M, Meschiari M, Mussini C, et al
    The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  234. KERNEIS S, Lucet JC, Santoro A, Meschiari M, et al
    Individual and collective impact of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in patients admitted to the ICU.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  235. PAUL M
    Management of KPC-producing Klebsiella pneumoniae in clinical practice: introduction.
    J Antimicrob Chemother. 2021;76.
    PubMed    


  236. GOMEZ-SIMMONDS A, Annavajhala MK, McConville TH, Dietz DE, et al
    Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital.
    J Antimicrob Chemother. 2021;76:380-384.
    PubMed     Abstract available


  237. MOSER AI, Kuenzli E, Budel T, Campos-Madueno EI, et al
    Travellers returning from the island of Zanzibar colonized with MDR Escherichia coli strains: assessing the impact of local people and other sources.
    J Antimicrob Chemother. 2021;76:330-337.
    PubMed     Abstract available


  238. CAMARA J, Grau I, Gonzalez-Diaz A, Tubau F, et al
    A historical perspective of MDR invasive pneumococcal disease in Spanish adults.
    J Antimicrob Chemother. 2021;76:507-515.
    PubMed     Abstract available


  239. MARI-ALMIRALL M, Cosgaya C, Pitart C, Vines J, et al
    Dissemination of NDM-producing Klebsiella pneumoniae and Escherichia coli high-risk clones in Catalan healthcare institutions.
    J Antimicrob Chemother. 2021;76:345-354.
    PubMed     Abstract available


  240. DI PILATO V, Errico G, Monaco M, Giani T, et al
    The changing epidemiology of carbapenemase-producing Klebsiella pneumoniae in Italy: toward polyclonal evolution with emergence of high-risk lineages.
    J Antimicrob Chemother. 2021;76:355-361.
    PubMed     Abstract available


  241. PAULY N, Hammerl JA, Schwarz S, Grobbel M, et al
    Co-occurrence of the blaVIM-1 and blaSHV-12 genes on an IncHI2 plasmid of an Escherichia coli isolate recovered from German livestock.
    J Antimicrob Chemother. 2021;76:531-533.
    PubMed    


  242. SILVA L, Grosso F, Rodrigues C, Ksiezarek M, et al
    The success of particular Acinetobacter baumannii clones: accumulating resistance and virulence inside a sugary shield.
    J Antimicrob Chemother. 2021;76:305-311.
    PubMed     Abstract available


  243. AULIN LBS, Koumans CIM, Haakman Y, van Os W, et al
    Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021;76:533-535.
    PubMed    


  244. MAILLARD A, Scemla A, Laffy B, Mahloul N, et al
    Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study.
    J Antimicrob Chemother. 2021;76:487-494.
    PubMed     Abstract available


  245. LI LH, Yang YS, Sun JR, Huang TW, et al
    Clinical and molecular characterization of Acinetobacter seifertii in Taiwan.
    J Antimicrob Chemother. 2021;76:312-321.
    PubMed     Abstract available


  246. LEE YM, Moon C, Park KH
    Is short-term antibiotic therapy safe in patients with central venous catheter-related Gram-negative bacteraemia?
    J Antimicrob Chemother. 2021;76:539-541.
    PubMed    


  247. HERNANDEZ-GARCIA M, Garcia-Castillo M, Garcia-Fernandez S, Melo-Cristino J, et al
    Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
    J Antimicrob Chemother. 2021;76:370-379.
    PubMed     Abstract available


  248. AIHARA M, Nishida R, Akimoto M, Gotoh Y, et al
    Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistance.
    J Antimicrob Chemother. 2021;76:362-369.
    PubMed     Abstract available


  249. HAMIDIAN M, Ambrose SJ, Blackwell GA, Nigro SJ, et al
    An outbreak of multiply antibiotic-resistant ST49:ST128:KL11:OCL8 Acinetobacter baumannii isolates at a Sydney hospital.
    J Antimicrob Chemother. 2021 Jan 16. pii: 6102239. doi: 10.1093.
    PubMed     Abstract available


  250. SWEENEY EL, Lowry K, Bletchly C, Nimmo GR, et al
    Mycoplasma genitalium infections can comprise a mixture of both fluoroquinolone-susceptible and fluoroquinolone-resistant strains.
    J Antimicrob Chemother. 2021 Jan 15. pii: 6100778. doi: 10.1093.
    PubMed     Abstract available


  251. ZHU Y, Zhang W, Liu S, Schwarz S, et al
    Identification of an IS431-derived translocatable unit containing the erm(C) gene in Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jan 11. pii: 6082781. doi: 10.1093.
    PubMed    


  252. GOLPARIAN D, Sanchez-Buso L, Cole M, Unemo M, et al
    Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions.
    J Antimicrob Chemother. 2021 Jan 7. pii: 6067623. doi: 10.1093.
    PubMed     Abstract available


  253. BUDIN S, Salmanton-Garcia J, Koehler P, Stemler J, et al
    Validation of the EQUAL Aspergillosis Score by analysing guideline-adherent management of invasive pulmonary aspergillosis.
    J Antimicrob Chemother. 2021 Jan 4. pii: 6062083. doi: 10.1093.
    PubMed     Abstract available


  254. OUESLATI S, Volland H, Cattoir V, Bernabeu S, et al
    Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
    J Antimicrob Chemother. 2021;76:146-151.
    PubMed     Abstract available


  255. BEZABIH YM, Sabiiti W, Alamneh E, Bezabih A, et al
    The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community.
    J Antimicrob Chemother. 2021;76:22-29.
    PubMed     Abstract available


  256. ARCA-SUAREZ J, Lasarte-Monterrubio C, Rodino-Janeiro BK, Cabot G, et al
    Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections.
    J Antimicrob Chemother. 2021;76:91-100.
    PubMed     Abstract available


  257. DUGGETT N, Ellington MJ, Hopkins KL, Ellaby N, et al
    Detection in livestock of the human pandemic Escherichia coli ST131 fimH30(R) clone carrying blaCTX-M-27.
    J Antimicrob Chemother. 2021;76:263-265.
    PubMed    


  258. KHANINA A, Urbancic KF, Haeusler GM, Kong DCM, et al
    Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey.
    J Antimicrob Chemother. 2021;76:253-262.
    PubMed     Abstract available


  259. PEREZ-VISO B, Hernandez-Garcia M, Ponce-Alonso M, Morosini MI, et al
    Characterization of carbapenemase-producing Serratia marcescens and whole-genome sequencing for plasmid typing in a hospital in Madrid, Spain (2016-18).
    J Antimicrob Chemother. 2021;76:110-116.
    PubMed     Abstract available


  260. TREMBIZKI E, Jennison AV, Buckley C, Bright A, et al
    Enhanced molecular surveillance in response to the detection of extensively resistant gonorrhoea in Australia.
    J Antimicrob Chemother. 2021;76:270-271.
    PubMed    


  261. LOUKA C, Ravensbergen SJ, Ott A, Zhou X, et al
    Predominance of CTX-M-15-producing ST131 strains among ESBL-producing Escherichia coli isolated from asylum seekers in the Netherlands.
    J Antimicrob Chemother. 2021;76:70-76.
    PubMed     Abstract available


  262. BOEL JB, Antsupova V, Knudsen JD, Jarlov JO, et al
    Intravenous mecillinam compared with other beta-lactams as targeted treatment for Escherichia coli or Klebsiella spp. bacteraemia with urinary tract focus.
    J Antimicrob Chemother. 2021;76:206-211.
    PubMed     Abstract available


  263. TANG Y, Lai Y, Kong L, Wang X, et al
    Characterization of three porcine Escherichia coli isolates co-harbouring tet(X4) and cfr.
    J Antimicrob Chemother. 2021;76:263-264.
    PubMed    


  264. KUMWENDA GP, Sugawara Y, Akeda Y, Matsumoto Y, et al
    Genomic features of plasmids coding for KPC-2, NDM-5 or OXA-48 carbapenemases in Enterobacteriaceae from Malawi.
    J Antimicrob Chemother. 2021;76:267-270.
    PubMed    


  265. ABBOTSFORD J, Foley DA, Goff Z, Bowen AC, et al
    Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital.
    J Antimicrob Chemother. 2021;76:249-252.
    PubMed     Abstract available


  266. BUCKLEY AM, Altringham J, Clark E, Bently K, et al
    Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut model.
    J Antimicrob Chemother. 2021;76:171-178.
    PubMed     Abstract available


    December 2020
  267. ALGHAMDI WA, Al-Shaer MH, Kipiani M, Barbakadze K, et al
    Pharmacokinetics of bedaquiline, delamanid and clofazimine in patients with multidrug-resistant tuberculosis.
    J Antimicrob Chemother. 2020 Dec 30. pii: 6055881. doi: 10.1093.
    PubMed     Abstract available


  268. CRUCIANI M, White PL, Mengoli C, Loffler J, et al
    The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis.
    J Antimicrob Chemother. 2020 Dec 29. pii: 6055077. doi: 10.1093.
    PubMed     Abstract available


  269. WEINER M, Gelfond J, Johnson-Pais TL, Engle M, et al
    Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis.
    J Antimicrob Chemother. 2020 Dec 29. pii: 6055076. doi: 10.1093.
    PubMed     Abstract available


  270. XANTHOPOULOU K, Wille J, Zweigner J, Lucassen K, et al
    Characterization of a vancomycin-resistant Enterococcus faecium isolate and a vancomycin-susceptible E. faecium isolate from the same blood culture.
    J Antimicrob Chemother. 2020 Dec 28. pii: 6054276. doi: 10.1093.
    PubMed     Abstract available


  271. WAGNER TM, Janice J, Sivertsen A, Sjogren I, et al
    Alternative vanHAX promoters and increased vanA-plasmid copy number resurrect silenced glycopeptide resistance in Enterococcus faecium.
    J Antimicrob Chemother. 2020 Dec 26. pii: 6050581. doi: 10.1093.
    PubMed     Abstract available


  272. BLACKMAN A, Morrison B, Maruri F, van der Heijden Y, et al
    Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2020 Dec 23. pii: 6046147. doi: 10.1093.
    PubMed    


  273. LARRAMENDY S, Gaultier A, Fournier JP, Caillon J, et al
    Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study.
    J Antimicrob Chemother. 2020 Dec 22. pii: 6042378. doi: 10.1093.
    PubMed     Abstract available


  274. TAHSEEN S, vanDeun A, de Jong BC, Decroo T, et al
    Second-line injectable drugs for rifampicin-resistant tuberculosis: better the devil we know?
    J Antimicrob Chemother. 2020 Dec 1. pii: 6015577. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  275. ZHU Y, Wang C, Schwarz S, Liu W, et al
    Identification of a novel tetracycline resistance gene, tet(63), located on a multiresistance plasmid from Staphylococcus aureus.
    J Antimicrob Chemother. 2020 Nov 28. pii: 6008797. doi: 10.1093.
    PubMed     Abstract available


  276. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Ilkit M, et al
    Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2020 Nov 11. pii: 5974114. doi: 10.1093.
    PubMed     Abstract available


  277. SHROPSHIRE WC, Aitken SL, Pifer R, Kim J, et al
    IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort.
    J Antimicrob Chemother. 2020 Nov 9. pii: 5961599. doi: 10.1093.
    PubMed     Abstract available


  278. HAYAJNEH WA, Al-Azzam S, Yusef D, Lattyak WJ, et al
    Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan.
    J Antimicrob Chemother. 2020 Nov 5. pii: 5957247. doi: 10.1093.
    PubMed     Abstract available


  279. MIZUSHIMA D, Takano M, Uemura H, Yanagawa Y, et al
    Effectiveness of doxycycline 100 mg twice daily for 7 days and azithromycin 1 g single dose for the treatment of rectal Chlamydia trachomatis infection among men who have sex with men.
    J Antimicrob Chemother. 2020 Nov 4. pii: 5955928. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  280. TKADLEC J, Capek V, Brajerova M, Smelikova E, et al
    The molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the Czech Republic.
    J Antimicrob Chemother. 2020 Oct 29. pii: 5942696. doi: 10.1093.
    PubMed     Abstract available


  281. GUIRAUD J, Lounnas M, Boissiere A, Le Roy C, et al
    Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2020 Oct 20. pii: 5930856. doi: 10.1093.
    PubMed     Abstract available


  282. YANG Q, Li X, Jia P, Giske C, et al
    Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis.
    J Antimicrob Chemother. 2020 Oct 14. pii: 5923762. doi: 10.1093.
    PubMed     Abstract available


  283. ARA-MONTOJO MF, Escosa-Garcia L, Alguacil-Guillen M, Seara N, et al
    Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
    J Antimicrob Chemother. 2020 Oct 10. pii: 5920733. doi: 10.1093.
    PubMed     Abstract available


  284. PAPATHANAKOS G, Andrianopoulos I, Papathanasiou A, Koulenti D, et al
    Pandrug-resistant Acinetobacter baumannii treatment: still a debatable topic with no definite solutions.
    J Antimicrob Chemother. 2020;75:3081.
    PubMed    


    September 2020
  285. HADAD R, Cole MJ, Ebeyan S, Jacobsson S, et al
    Evaluation of the SpeeDx ResistancePlus(R) GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905664. doi: 10.1093.
    PubMed     Abstract available


  286. ROUX J, Nekkab N, Colomb-Cotinat M, Astagneau P, et al
    Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905635. doi: 10.1093.
    PubMed     Abstract available


  287. AMBROSE SJ, Hall RM
    A novel trimethoprim resistance gene, dfrA38, found in a sporadic Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905668. doi: 10.1093.
    PubMed    


    August 2020
  288. RICHELSEN R, Smit J, Schonheyder HC, Laxsen Anru P, et al
    Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899248. doi: 10.1093.
    PubMed     Abstract available


  289. DIACONU EL, Carfora V, Alba P, Di Matteo P, et al
    Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy.
    J Antimicrob Chemother. 2020 Aug 24. pii: 5896583. doi: 10.1093.
    PubMed     Abstract available


  290. LYU T, Cheung KS, Ni L, Guo J, et al
    High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891805. doi: 10.1093.
    PubMed     Abstract available


  291. GOLPARIAN D, Bazzo ML, Golfetto L, Gaspar PC, et al
    Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891806. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  292. DAI VTT, Beissbarth J, Thanh PV, Hoan PT, et al
    Hospital surveillance predicts community pneumococcal antibiotic resistance in Vietnam.
    J Antimicrob Chemother. 2020 Jul 29. pii: 5878176. doi: 10.1093.
    PubMed     Abstract available


  293. LI Y, Xiu L, Liu J, Zhang C, et al
    A multiplex assay for characterization of antimicrobial resistance in Neisseria gonorrhoeae using multi-PCR coupled with mass spectrometry.
    J Antimicrob Chemother. 2020 Jul 20. pii: 5874078. doi: 10.1093.
    PubMed     Abstract available


  294. CHAN AP, Choi Y, Clarke TH, Brinkac LM, et al
    AbGRI4, a novel antibiotic resistance island in multiply antibiotic-resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2020 Jul 18. pii: 5873331. doi: 10.1093.
    PubMed     Abstract available


  295. ZHANG S, Wang X, Wise MJ, He Y, et al
    Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance.
    J Antimicrob Chemother. 2020 Jul 17. pii: 5872801. doi: 10.1093.
    PubMed     Abstract available


  296. RIVAYA B, Jordana-Lluch E, Fernandez-Rivas G, Molinos S, et al
    Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain.
    J Antimicrob Chemother. 2020 Jul 12. pii: 5870410. doi: 10.1093.
    PubMed     Abstract available


  297. CAO T, Liu Y, Li Y, Wang Y, et al
    A public health concern: emergence of carbapenem-resistant Klebsiella pneumoniae in a public transportation environment.
    J Antimicrob Chemother. 2020 Jul 4. pii: 5867249. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  298. SEIFERT H, Muller C, Stefanik D, Higgins PG, et al
    In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855123. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  299. LAM TT, Nurnberg S, Claus H, Vogel U, et al
    Molecular epidemiology of imipenem resistance in invasive Haemophilus influenzae infections in Germany in 2016.
    J Antimicrob Chemother. 2020 May 25. pii: 5843865. doi: 10.1093.
    PubMed     Abstract available


  300. STEWART AG, Harris PNA, Henderson A, Schembri MA, et al
    Oral cephalosporin and beta-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections.
    J Antimicrob Chemother. 2020 May 22. pii: 5842233. doi: 10.1093.
    PubMed     Abstract available


  301. DE LASTOURS V, Laouenan C, Royer G, Carbonnelle E, et al
    Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
    J Antimicrob Chemother. 2020 May 17. pii: 5838343. doi: 10.1093.
    PubMed     Abstract available


  302. MARTINEZ EP, van Rosmalen J, Bustillos R, Natsch S, et al
    Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands.
    J Antimicrob Chemother. 2020 May 17. pii: 5838345. doi: 10.1093.
    PubMed     Abstract available


  303. CHANAME PINEDO LE, Bruyndonckx R, Catry B, Latour K, et al
    Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case-control study.
    J Antimicrob Chemother. 2020 May 12. pii: 5836063. doi: 10.1093.
    PubMed     Abstract available


  304. ABBOTT IJ, van Gorp E, Wijma RA, Dekker J, et al
    Efficacy of single and multiple oral doses of fosfomycin against Pseudomonas aeruginosa urinary tract infections in a dynamic in vitro bladder infection model.
    J Antimicrob Chemother. 2020 May 3. pii: 5828355. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  305. ROHDE AM, Zweigner J, Wiese-Posselt M, Schwab F, et al
    Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitals.
    J Antimicrob Chemother. 2020 Mar 16. pii: 5805542. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  306. LAN PT, Golparian D, Ringlander J, Van Hung L, et al
    Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015-16.
    J Antimicrob Chemother. 2020 Feb 18. pii: 5740025. doi: 10.1093.
    PubMed     Abstract available


  307. BOURELY C, Coeffic T, Caillon J, Thibaut S, et al
    Trends in antimicrobial resistance among Escherichia coli from defined infections in humans and animals.
    J Antimicrob Chemother. 2020 Feb 12. pii: 5734707. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  308. PAINSET A, Day M, Doumith M, Rigby J, et al
    Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Campylobacter jejuni and Campylobacter coli isolated from cases of diarrhoeal disease in England and Wales, 2015-16.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707358. doi: 10.1093.
    PubMed     Abstract available


  309. XIU L, Zhang C, Li Y, Wang F, et al
    High-resolution melting analysis for rapid detection of the internationally spreading ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone.
    J Antimicrob Chemother. 2020;75:106-109.
    PubMed     Abstract available


  310. SOREN O, Rineh A, Silva DG, Cai Y, et al
    Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2020;75:117-125.
    PubMed     Abstract available


  311. KIDD JM, Abdelraouf K, Nicolau DP
    Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model.
    J Antimicrob Chemother. 2020;75:149-155.
    PubMed     Abstract available


  312. PAUL D, Babenko D, Toleman MA
    Human carriage of cefotaxime-resistant Escherichia coli in North-East India: an analysis of STs and associated resistance mechanisms.
    J Antimicrob Chemother. 2020;75:72-76.
    PubMed     Abstract available


  313. WAREHAM DW, Momin MHFA, Phee LM, Hornsey M, et al
    Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
    J Antimicrob Chemother. 2020;75:135-139.
    PubMed     Abstract available


  314. KIM J, Nakwa FL, Araujo Motta F, Liu H, et al
    A randomized, double-blind trial investigating the efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants younger than 3 months of age.
    J Antimicrob Chemother. 2020;75:215-220.
    PubMed     Abstract available


  315. MARTINEZ-GUITIAN M, Vazquez-Ucha JC, Alvarez-Fraga L, Conde-Perez K, et al
    Antisense inhibition of lpxB gene expression in Acinetobacter baumannii by peptide-PNA conjugates and synergy with colistin.
    J Antimicrob Chemother. 2020;75:51-59.
    PubMed     Abstract available


  316. LUO Q, Wan F, Yu X, Zheng B, et al
    MDR Salmonella enterica serovar Typhimurium ST34 carrying mcr-1 isolated from cases of bloodstream and intestinal infection in children in China.
    J Antimicrob Chemother. 2020;75:92-95.
    PubMed     Abstract available


  317. SCHNEEWEISS S, Carver PL, Datta K, Galar A, et al
    Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.
    J Antimicrob Chemother. 2020;75:221-228.
    PubMed     Abstract available


  318. MARTINS-SORENSON N, Snesrud E, Xavier DE, Cacci LC, et al
    A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.
    J Antimicrob Chemother. 2020;75:60-64.
    PubMed     Abstract available


  319. FINDLAY J, Gould VC, North P, Bowker KE, et al
    Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.
    J Antimicrob Chemother. 2020;75:65-71.
    PubMed     Abstract available


    December 2019
  320. ABBOTT IJ, Dekker J, van Gorp E, Wijma RA, et al
    Impact of bacterial species and baseline resistance on fosfomycin efficacy in urinary tract infections.
    J Antimicrob Chemother. 2019 Dec 24. pii: 5686404. doi: 10.1093.
    PubMed     Abstract available


  321. LO SW, Gladstone RA, van Tonder AJ, Du Plessis M, et al
    A mosaic tetracycline resistance gene tet(S/M) detected in an MDR pneumococcal CC230 lineage that underwent capsular switching in South Africa.
    J Antimicrob Chemother. 2019 Dec 2. pii: 5650366. doi: 10.1093.
    PubMed     Abstract available


  322. HAYAKAWA K, Nakano R, Hase R, Shimatani M, et al
    Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
    J Antimicrob Chemother. 2019 Dec 2. pii: 5650359. doi: 10.1093.
    PubMed     Abstract available


  323. SAVOLDI A, Carrara E, Gladstone BP, Azzini AM, et al
    Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list.
    J Antimicrob Chemother. 2019;74:3619-3625.
    PubMed     Abstract available


    November 2019
  324. LESTER R, Musicha P, van Ginneken N, Dramowski A, et al
    Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
    J Antimicrob Chemother. 2019 Nov 19. pii: 5632029. doi: 10.1093.
    PubMed     Abstract available


  325. ZHANG Y, Jin L, Ouyang P, Wang Q, et al
    Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis.
    J Antimicrob Chemother. 2019 Nov 12. pii: 5622907. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  326. BRITTO CD, Dyson ZA, Mathias S, Bosco A, et al
    Persistent circulation of a fluoroquinolone-resistant Salmonella enterica Typhi clone in the Indian subcontinent.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607520. doi: 10.1093.
    PubMed     Abstract available


  327. JAHAN MI, Rahaman MM, Hossain MA, Sultana M, et al
    Occurrence of intI1-associated VIM-5 carbapenemase and co-existence of all four classes of beta-lactamase in carbapenem-resistant clinical Pseudomonas aeruginosa DMC-27b.
    J Antimicrob Chemother. 2019 Oct 24. pii: 5606763. doi: 10.1093.
    PubMed     Abstract available


  328. BIRGY A, Madhi F, Jung C, Levy C, et al
    Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588579. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  329. EIGENBROD T, Reuter S, Gross A, Kocer K, et al
    Molecular characterization of carbapenem-resistant Acinetobacter baumannii using WGS revealed missed transmission events in Germany from 2012-15.
    J Antimicrob Chemother. 2019 Aug 31. pii: 5557811. doi: 10.1093.
    PubMed     Abstract available


  330. COOMBS GW, Mowlaboccus S, Daley D, Lee T, et al
    Sulfamethoxazole/trimethoprim resistance overcall by VITEK(R) 2 and BD Phoenix in community-associated MRSA and MSSA.
    J Antimicrob Chemother. 2019 Aug 20. pii: 5552317. doi: 10.1093.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: